Arrowhead Pharmaceuticals breaks ground on Verona expansion
Arrowhead Pharmaceuticals, a genetic medicine company, broke ground on its $220 million expansion in Verona on Monday.
To access this content, you must purchase a Premium membership, or log in if you are a member.
